{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:00:42Z","timestamp":1790805642660,"version":"4.1.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH.NCI PO1 CA94237 (CMR)"],"award-info":[{"award-number":["NIH.NCI PO1 CA94237 (CMR)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002730","name":"Children's Neuroblastoma Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00343","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T05:29:50Z","timestamp":1544506190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells"],"prefix":"10.3389","volume":"5","author":[{"given":"Bilal","family":"Omer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai T. A.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Lapteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schmueck-Henneresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona M.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Disco."},{"key":"B2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J Clin Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/mto.2016.6","article-title":"Chimeric antigen receptor T-cell therapy for solid tumors","volume":"3","author":"Newick","year":"2016","journal-title":"Mol Ther Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1182\/blood-2013-06-506741","article-title":"Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study","volume":"122","author":"Cruz","year":"2013","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1158\/1078-0432.CCR-14-2998","article-title":"K562-derived whole-cell vaccine enhances antitumor responses of car-redirected virus-specific cytotoxic t lymphocytes in vivo","volume":"21","author":"Caruana","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/1078-0432.CCR-16-2138","article-title":"Vaccination targeting native receptors to enhance the function and proliferation of chimeric antigen receptor (CAR)-modified T cells","volume":"23","author":"Tanaka","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4\u20131BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/sj.cgt.7701034","article-title":"Antitumor activity of dual-specific T cells and influenza virus","volume":"14","author":"Murphy","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.cji.0000175492.28723.d6","article-title":"Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors","volume":"29","author":"Rossig","year":"2006","journal-title":"J Immunother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2249.2006.03095.x","article-title":"CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells","volume":"144","author":"Altvater","year":"2006","journal-title":"Clin Exp Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/mt.sj.6300134","article-title":"Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules","volume":"15","author":"Suhoski","year":"2007","journal-title":"Mol Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1182\/blood-2013-11-541235","article-title":"Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy","volume":"124","author":"Heczey","year":"2014","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ymthe.2005.04.016","article-title":"A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells","volume":"12","author":"Pule","year":"2005","journal-title":"Mol Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/CJI.0000000000000014","article-title":"Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity","volume":"37","author":"Ngo","year":"2014","journal-title":"J Immunother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40425-015-0049-1","article-title":"Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application","volume":"3","author":"Sun","year":"2015","journal-title":"J Immunother Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1182\/blood.V99.6.2009","article-title":"Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy","volume":"99","author":"Rossig","year":"2002","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1086\/315347","article-title":"Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression","volume":"181","author":"Asanuma","year":"2000","journal-title":"J Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1182\/blood-2002-11-3577","article-title":"Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines","volume":"101","author":"Geginat","year":"2003","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1182\/blood-2009-09-242263","article-title":"Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation","volume":"115","author":"Micklethwaite","year":"2010","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.181.5.1653","article-title":"Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes","volume":"181","author":"Brocker","year":"1995","journal-title":"J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1084\/jem.188.4.619","article-title":"Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes","volume":"188","author":"Krause","year":"1998","journal-title":"J Exp Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1084\/jem.183.5.2109","article-title":"Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis","volume":"183","author":"Combadiere","year":"1996","journal-title":"J Exp Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/35037728","article-title":"CD95's deadly mission in the immune system","volume":"407","author":"Krammer","year":"2000","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/373444a0","article-title":"Fas(CD95)\/FasL interactions required for programmed cell death after T-cell activation","volume":"373","author":"Ju","year":"1995","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.celrep.2017.09.015","article-title":"Tonic 4\u20131BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent","volume":"21","author":"Gomes-Silva","year":"2017","journal-title":"Cell Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1172\/JCI81217","article-title":"Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy","volume":"126","author":"Klebanoff","year":"2016","journal-title":"J Clin Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.4049\/jimmunol.179.10.6494","article-title":"Memory CD8+ T cells require CD28 costimulation","volume":"179","author":"Borowski","year":"2007","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7689","DOI":"10.4049\/jimmunol.177.11.7689","article-title":"Cyclosporin A abolishes CD28-mediated resistance to CD95-induced apoptosis via superinduction of caspase-3","volume":"177","author":"Kerstan","year":"2006","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 costimulation: from mechanism to therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ni.3386","article-title":"Control of T cell antigen reactivity via programmed TCR downregulation","volume":"17","author":"Gallegos","year":"2016","journal-title":"Nat Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1084\/jem.186.10.1775","article-title":"Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering","volume":"186","author":"Viola","year":"1997","journal-title":"J Exp Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.4049\/jimmunol.172.6.3662","article-title":"Architectural changes in the TCR:CD3 complex induced by MHC:peptide ligation","volume":"172","author":"La Gruta","year":"2004","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5483\/BMBRep.2014.47.3.283","article-title":"4\u20131BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy","volume":"47","author":"Vinay","year":"2014","journal-title":"BMB Rep."},{"key":"B37","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.162.9.5037","article-title":"Cutting edge: 4\u20131BB is a bona fide CD8 T cell survival signal","volume":"162","author":"Takahashi","year":"1999","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T Cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4049\/jimmunol.1601494","article-title":"Comprehensive approach for identifying the T cell subset origin of CD3 and CD28 antibody-activated chimeric antigen receptor-modified T cells","volume":"199","author":"Schmueck-Henneresse","year":"2017","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1182\/blood-2011-07-366419","article-title":"Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells","volume":"119","author":"Terakura","year":"2012","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood-2006-11-059139","article-title":"Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease","volume":"110","author":"Savoldo","year":"2007","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"683065","DOI":"10.1155\/2012\/683065","article-title":"In vitro and in vivo antitumor effect of anti-CD33 chimeric receptor-expressing EBV-CTL against CD33 acute myeloid leukemia","volume":"2012","author":"Dutour","year":"2012","journal-title":"Adv Hematol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1182\/blood-2011-05-354449","article-title":"Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma","volume":"118","author":"Louis","year":"2011","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/mt.2011.131","article-title":"PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor","volume":"19","author":"Nakazawa","year":"2011","journal-title":"Mol Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.1158\/0008-5472.CAN-06-4426","article-title":"Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function","volume":"67","author":"Landmeier","year":"2007","journal-title":"Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1182\/blood-2004-03-1208","article-title":"Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1","volume":"105","author":"Cooper","year":"2005","journal-title":"Blood"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00343\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:37:44Z","timestamp":1694479064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00343\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":47,"alternative-id":["10.3389\/fmed.2018.00343"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00343","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"article-number":"343"}}